Clinical Trial

Electrophysiological Signature of Mild Cognitive Impairment and Its Relationship with Parkinson's Disease: a High-density EEG Investigation

Study acronym: MMCI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated December 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
The study aims to investigate neural correlate of Mild Cognitive Impairment (MCI) in Parkinson's disease (PD) and to identify a link between functional impairment (in both cognitive and motor domains) and electrophysiological cortical sing of MCI in PD. A sample of 42 subjects will be divide into three subgroup: healthy control, PD with MCI (PD-MCI) and PD without MCI (PD-ctrl). Those subjects will undergo a specific neuropsychological evaluation and, to measure the electro-cortical activity, high-density electroencephalography (hdEEG) will be record during both resting state and cognitive tasks. Furthermore, hdEEG data will be combine with structural magnetic resonance to obtain information about network connectivity.
Trial Details
NCT Number NCT06640673
Lead Sponsor IRCCS San Camillo, Venezia, Italy
Conditions Parkinson Disease, Parkinson Disease, Mild Cognitive Impairment, Healthy
Enrollment 42 participants
Start Date 2023-06-18
Primary Completion 2024-12-01 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2024-10-15